MAY DEAL ACTIVITY: Amidst challenging market conditions, Oaklins sees M&A as a vital corporate strategy to build resilience and outperform competit...
Read article
Netherlands Netherlands MAY DEAL ACTIVITY: Amidst challenging market conditions, Oaklins sees M&A as a vital corporate strategy to build resilience and outperform competit...
Read articleMONTHLY DEAL ACTIVITY: 2022 has got off to a good start for Oaklins with 36 closed transactions of which 34 were M&A deals and two were fundraising...
Read articleMONTHLY DEAL ACTIVITY: In November 2021, we closed 40 transactions of which 31 were M&A deals and 9 were fundraising deals. The surge in deal activ...
Read articleMONTHLY DEAL ACTIVITY: In October 2021, we closed 27 transactions of which 20 were M&A deals and 7 were fundraising deals. We expect deal activity ...
Read articleDEAL FLASH: Ace Pharmaceuticals (Ace) has been acquired by a consortium of Gilde Buy Out Partners, Gilde Healthcare, Quadrum Capital and Ace’s mana...
Read articleOaklins supports investor Mentha Capital in its announced acquisition of a majority stake in BlijWerkt and paraDIGMA group. The new business combin...
Read articleEnterprises ImportFab Inc. has been acquired by Labomar S.p.a, a leading Italian contract development manufacturing organization. Oaklins’ team in ...
Read articleDEAL FLASH: MJH Associates, Inc. has acquired major market media assets from the UBM Life Sciences Group of Informa PLC. This acquisition creates t...
Read articleDEAL FLASH: Oaklins’ team in Italy has advised Lifco AB, a Swedish investment group, on the acquisition of a majority stake in Rhein83 Srl. Lifco a...
Read articleDEAL FLASH: Oaklins’ team in Germany has advised the private shareholders of Acutronic Group, a group on non-affiliated companies active in neonata...
Read articleDEAL FLASH: Oaklins’ team in Germany and our healthcare specialist in New York have advised the shareholders of Vascotube GmbH, a global manufactur...
Read article